Miller, P., Cheung, A. M., Reid, I., Rojeski, M., Vanderkelen, M., Yang, W., . . . Oates, M. (2020). MON-378 Efficacy and Safety of Romosozumab vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women with Osteoporosis. J Endocr Soc.
Chicago Style CitationMiller, Paul, Angela M. Cheung, Ian Reid, Maria Rojeski, Mark Vanderkelen, Wenjing Yang, Norma Ruiz Santiago, i Mary Oates. "MON-378 Efficacy and Safety of Romosozumab Vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women With Osteoporosis." J Endocr Soc 2020.
Cita MLAMiller, Paul, et al. "MON-378 Efficacy and Safety of Romosozumab Vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women With Osteoporosis." J Endocr Soc 2020.